Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity in Patients With Rheumatoid Arthritis and Osteoarthritis

NCT06540573 is registered in ClinicalTrials.gov with Gaziosmanpasa Research and Education Hospital as lead sponsor.

NCT NCT06540573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06540573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity in Patients With Rheumatoid Arthritis and Osteoarthritis
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 12, 2024
Completion date
November 30, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, rheumatoid arthritis